Pharma news
Pharma
The UK Intellectual Property Office has revealed the location for the country’s central and local divisions of the forthcoming Unified Patent Court. 12 August 2015
Americas
Law firm Gibson Dunn has hired Jane Love and Robert Trenchard as partners in its New York office. 10 August 2015
Americas
Drugs companies Sandoz and Lupin have failed to reverse a US court’s ruling that they infringed patents owned by Allergan. 5 August 2015
Africa
Worldwide applications for pharmaceutical patents “peaked sharply” in 2014, reaching around 28,000, a report has shown. 4 August 2015
Americas
Pharmaceutical company Celgene has requested that the US Patent and Trademark Office sanctions hedge fund manager Kyle Bass and his company the Coalition for Affordable Drugs, arguing that the inter partes review petitions he has filed are “abusive” and a “tool to affect the stock prices of public companies”. 31 July 2015
Americas
On July 21 the US Court of Appeals for the Federal Circuit ruled in Amgen v Sandoz that biosimilar applicants can opt out of the ‘patent dance’. Courtenay Brinckerhoff of Foley & Lardner considers the decision’s implications for the biosimilars framework and highlights the questions that remain unanswered. 30 July 2015
Pharma
Bayer has claimed victory after a US district court ruled that a generic version of one of its skin treatment drugs proposed by Glenmark Pharmaceuticals infringed its patent. 28 July 2015
Americas
Biotechnology company United Therapeutics has sued Watson Laboratories claiming it has infringed three of its patents covering one of its hypertension treatment drugs. 24 July 2015
Americas
Law firm Hughes Hubbard & Reed has expanded its intellectual property practice by hiring Patrice Jean as a partner. 23 July 2015
Americas
Biopharma parties thinking about challenging a patent via an inter partes review should be aware that there are significant differences between district court and IPR practice, as Tasha Francis and Dorothy Whelan of Fish & Richardson explain. 23 July 2015